Intrathecal injection in MaFIA mouse model inflicts localized reduction of macrophage populations within the dorsal

Samuel B Chivers1, Cassandra L McLay1, Nathaniel A Jeske1,2,3

  • 1Departments of Oral and Maxillofacial Surgery, Center for Pain Therapeutics and Addiction Research, University of Texas Health San Antonio, TX, USA.

Molecular Pain
|August 17, 2026
PubMed

Insights

Researchers used the Macrophage Fas-Induced Apoptosis (MaFIA) mouse model to investigate macrophage origins in the nervous system. Targeted drug delivery prevented macrophage expansion in dorsal root ganglia during chronic intermittent hypoxia, indicating tissue-resident cells are responsible.

Area of Science:

  • Neuroimmunology
  • Innate Immune System

Background:

  • Macrophages play a key role in nervous system functions, particularly in somatosensory pathways within dorsal root ganglia (DRG).
  • Previous studies noted increased DRG macrophage numbers in preclinical pain models without identifying their origin.

Purpose of the Study:

  • To investigate the source of macrophage expansion in DRG using the Macrophage Fas-Induced Apoptosis (MaFIA) mouse model.
  • To determine if resident DRG macrophages contribute to the observed cell number increase during chronic intermittent hypoxia.

Main Methods:

  • Utilized the MaFIA transgenic mouse model for targeted apoptosis induction.
  • Administered AP20187 intrathecally to selectively eliminate central nervous system and DRG macrophages, leveraging blood-brain barrier impermeability.
  • Exposed treated MaFIA mice to chronic intermittent hypoxia.

Main Results:

  • Intrathecal AP20187 successfully reduced macrophage populations in the spinal column and DRG without affecting systemic sites like bone marrow or blood.
  • MaFIA mice treated with AP20187 did not exhibit an increase in DRG macrophage numbers following chronic intermittent hypoxia exposure.
  • These results demonstrate that circulating monocytes are not the source of hypoxia-induced DRG macrophage expansion.

Conclusions:

  • Targeted intrathecal administration of AP20187 effectively reduces DRG tissue-resident macrophages.
  • This targeted approach prevents the expansion of innate immune cells in DRG during chronic intermittent hypoxia.
  • The findings negate a role for circulating monocytes in the observed DRG macrophage proliferation under hypoxic conditions.

Related Concept Videos